CES1 also hydrolyzes cholesteryl ester in lipid metabolism in human macrophages and hepatocytes, inferring that CES1 could be a potential drug target for the treatment of metabolic diseases, such as diabetes and atherosclerosis [10,11,12,13]. Here, CES1 is linked to metabolic disease.